The answer is 17 years, what is the question: understanding time lags in translational research
Top Cited Papers
Open Access
- 16 December 2011
- journal article
- review article
- Published by SAGE Publications in Journal of the Royal Society of Medicine
- Vol. 104 (12) , 510-520
- https://doi.org/10.1258/jrsm.2011.110180
Abstract
This study aimed to review the literature describing and quantifying time lags in the health research translation process. Papers were included in the review if they quantified time lags in the development of health interventions. The study identified 23 papers. Few were comparable as different studies use different measures, of different things, at different time points. We concluded that the current state of knowledge of time lags is of limited use to those responsible for R&D and knowledge transfer who face difficulties in knowing what they should or can do to reduce time lags. This effectively ‘blindfolds’ investment decisions and risks wasting effort. The study concludes that understanding lags first requires agreeing models, definitions and measures, which can be applied in practice. A second task would be to develop a process by which to gather these data.Keywords
This publication has 57 references indexed in Scilit:
- The Emergence of Translational Epidemiology: From Scientific Discovery to Population Health ImpactAmerican Journal of Epidemiology, 2010
- Knowledge sources, patent protection, and commercialization of pharmaceutical innovationsResearch Policy, 2010
- Crossing the Research Valleys of Death: The University of Pittsburgh ApproachClinical and Translational Science, 2008
- Gap in publication of comparative information on new medicinesBritish Journal of Clinical Pharmacology, 2008
- The Meaning of Translational Research and Why It MattersJAMA, 2008
- Time to publication for results of clinical trialsCochrane Database of Systematic Reviews, 2007
- Practice-Based Research—“Blue Highways” on the NIH RoadmapJAMA, 2007
- Diffusion of Innovations in Service Organizations: Systematic Review and RecommendationsThe Milbank Quarterly, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Public–private interaction in pharmaceutical researchProceedings of the National Academy of Sciences, 1996